Profil
Paul Lévesque is President & Chief Executive Officer at Theratechnologies, Inc. since 2020.
Formerly, Mr. Lévesque was Global President-Rare Disease at Pfizer Inc. from 2018 to 2020 and Vice President-France & Canada Marketing at PF Consumer Healthcare Canada ULC.
Mr. Lévesque completed undergraduate studies at Université Laval.
Aktive Positionen von Paul Lévesque
| Unternehmen | Position | Beginn |
|---|---|---|
| THERATECHNOLOGIES INC. | Vorstandsvorsitzender | 06.04.2020 |
Ehemalige bekannte Positionen von Paul Lévesque
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 06.04.2020 |
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology Produces anti-infective, anti-inflammatory, cardiovascular and consumer healthcare products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Paul Lévesque
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Theratechnologies, Inc.
Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
PF Consumer Healthcare Canada ULC
PF Consumer Healthcare Canada ULC Pharmaceuticals: MajorHealth Technology Produces anti-infective, anti-inflammatory, cardiovascular and consumer healthcare products | Health Technology |
Université Laval
Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















